<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03576118</url>
  </required_header>
  <id_info>
    <org_study_id>AJIRB-MED-OBS-18-115</org_study_id>
    <nct_id>NCT03576118</nct_id>
  </id_info>
  <brief_title>Moderate vs Deep Neuromuscular Block on Biotrauma During Laparoscopy</brief_title>
  <official_title>The Effects of Moderate Versus Deep Neuromuscular Block on Respiratory Mechanics and Biotrauma in Patients With Intraoperative Protective Lung Ventilation for Laparoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ajou University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ajou University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purposes of this study is to investigate the effects of moderate vs. deep neuromuscular
      block on respiratory mechanics and biotrauma in patients with intraoperative protective lung
      ventilation for laparoscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mechanical ventilation results in the disruption of the alveolar-capillary barrier and
      increased permeability, a hallmark of experimental ventilator-induced lung injury. These
      mechanical forces also induce an increase in the concentrations of inflammatory cytokines.

      The benefits of deep neuromuscular blocks for laparoscopic procedures are controversial and
      most of the studies undertaken have only sought to improve surgical conditions.
      Theoretically, deep neuromuscular block permits a lower abdominal insufflation pressure,
      which leads to better respiratory mechanics and gas exchange. The investigators examined the
      effects of moderate vs. deep neuromuscular block on respiratory mechanics and biotrauma in
      patients with intraoperative protective lung ventilation for laparoscopy. The investigators
      hypothesized that deep neuromuscular block (PTC 1 or 2) and low pressure pneumoperitoneum (8
      mmHg) would improve respiratory mechanics and reduce inflammatory processes associated with
      biotrama during mechanical ventilation compared with moderate neuromuscular block (TOF count
      1 or 2 ) and standard pressure pneumoperitoneum (12-15 mmHg).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 5, 2018</start_date>
  <completion_date type="Actual">September 19, 2019</completion_date>
  <primary_completion_date type="Actual">July 12, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Cytokine</measure>
    <time_frame>baseline, end of pneumoperitoneum, 24 hr after surgery</time_frame>
    <description>change of IL-6 (pg/ml)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">74</enrollment>
  <condition>Pneumoperitoneum</condition>
  <arm_group>
    <arm_group_label>Deep neuromuscular block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Deep neuromuscular relaxation and low pressure pneumoperitoneum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate neuromuscular block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Moderate neuromuscular relaxation and standard pressure pneumoperitoneum</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Deep neuromuscular block</intervention_name>
    <description>Deep neuromuscular block using high dose rocuronium and 8 mmHg pneumoperitoneum</description>
    <arm_group_label>Deep neuromuscular block</arm_group_label>
    <other_name>Deep neuromuscular block with rocumeron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Moderate neuromuscular block</intervention_name>
    <description>Moderate neuromuscular block using moderate dose rocuronium and 12-15 mmHg pneumoperitoneum</description>
    <arm_group_label>Moderate neuromuscular block</arm_group_label>
    <other_name>Moderate neuromuscular block with rocumeron</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA physical status I or II, aged 25 to 80 years, scheduled for laparoscopic surgery
             with trendelenburg position

        Exclusion Criteria:

          -  cerebrovascular disease

          -  uncontrolled hypertension, asthma, COPD

          -  neuromuscular disorder

          -  patients who have had abdominal surgery

          -  morbid obesity (body mass index &gt; 35 kg/m2)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jong Yeop Kim</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ajou University Hospital, Suwon, Gyeongki-do, Korea,</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ajou University Hospital</name>
      <address>
        <city>Suwon</city>
        <state>Gyeonggi-do</state>
        <zip>16499</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>June 14, 2018</study_first_submitted>
  <study_first_submitted_qc>June 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 3, 2018</study_first_posted>
  <results_first_submitted>March 28, 2020</results_first_submitted>
  <results_first_submitted_qc>May 31, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">June 11, 2020</results_first_posted>
  <last_update_submitted>May 31, 2020</last_update_submitted>
  <last_update_submitted_qc>May 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ajou University School of Medicine</investigator_affiliation>
    <investigator_full_name>Jong Yeop Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>biotrauma</keyword>
  <keyword>laparoscopic surgery</keyword>
  <keyword>neuromuscular block</keyword>
  <keyword>sugammadex</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumoperitoneum</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 1, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/18/NCT03576118/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Deep Neuromuscular Block</title>
          <description>Deep neuromuscular relaxation and low pressure pneumoperitoneum
Deep neuromuscular block: Deep neuromuscular block using high dose rocuronium and 8 mmHg pneumoperitoneum</description>
        </group>
        <group group_id="P2">
          <title>Moderate Neuromuscular Block</title>
          <description>Moderate neuromuscular relaxation and standard pressure pneumoperitoneum
Moderate neuromuscular block: Moderate neuromuscular block using moderate dose rocuronium and 12 mmHg pneumoperitoneum</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Deep Neuromuscular Block</title>
          <description>Deep neuromuscular relaxation and low pressure pneumoperitoneum
Deep neuromuscular block: Deep neuromuscular block using high dose rocuronium and 8 mmHg pneumoperitoneum</description>
        </group>
        <group group_id="B2">
          <title>Moderate Neuromuscular Block</title>
          <description>Moderate neuromuscular relaxation and standard pressure pneumoperitoneum
Moderate neuromuscular block: Moderate neuromuscular block using moderate dose rocuronium and 12 mmHg pneumoperitoneum</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="34"/>
            <count group_id="B2" value="33"/>
            <count group_id="B3" value="67"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43" spread="7"/>
                    <measurement group_id="B2" value="44" spread="9"/>
                    <measurement group_id="B3" value="44" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="67"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="67"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change of Cytokine</title>
        <description>change of IL-6 (pg/ml)</description>
        <time_frame>baseline, end of pneumoperitoneum, 24 hr after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Deep Neuromuscular Block</title>
            <description>Deep neuromuscular relaxation and low pressure pneumoperitoneum
Deep neuromuscular block: Deep neuromuscular block using high dose rocuronium and 8 mmHg pneumoperitoneum</description>
          </group>
          <group group_id="O2">
            <title>Moderate Neuromuscular Block</title>
            <description>Moderate neuromuscular relaxation and standard pressure pneumoperitoneum
Moderate neuromuscular block: Moderate neuromuscular block using moderate dose rocuronium and 12 mmHg pneumoperitoneum</description>
          </group>
        </group_list>
        <measure>
          <title>Change of Cytokine</title>
          <description>change of IL-6 (pg/ml)</description>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>IL-6, baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.9" spread="16.85"/>
                    <measurement group_id="O2" value="12.2" spread="8.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-6, end of pneumoperitoneum</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.4" spread="14.85"/>
                    <measurement group_id="O2" value="22.9" spread="9.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-6, 24 hr after surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.53" spread="16.29"/>
                    <measurement group_id="O2" value="32.9" spread="10.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>baseline, end of pneumoperitoneum, 24 hr after surgery</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Deep Neuromuscular Block</title>
          <description>Deep neuromuscular relaxation and low pressure pneumoperitoneum
Deep neuromuscular block: Deep neuromuscular block using high dose rocuronium and 8 mmHg pneumoperitoneum</description>
        </group>
        <group group_id="E2">
          <title>Moderate Neuromuscular Block</title>
          <description>Moderate neuromuscular relaxation and standard pressure pneumoperitoneum
Moderate neuromuscular block: Moderate neuromuscular block using moderate dose rocuronium and 12 mmHg pneumoperitoneum</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Jong Yeop Kim</name_or_title>
      <organization>Ajou University Hospital</organization>
      <phone>+82312195574</phone>
      <email>kjyeop@ajou.ac.kr</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

